JP2025517120A5 - - Google Patents
Info
- Publication number
- JP2025517120A5 JP2025517120A5 JP2024564796A JP2024564796A JP2025517120A5 JP 2025517120 A5 JP2025517120 A5 JP 2025517120A5 JP 2024564796 A JP2024564796 A JP 2024564796A JP 2024564796 A JP2024564796 A JP 2024564796A JP 2025517120 A5 JP2025517120 A5 JP 2025517120A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- nos
- albumin
- polypeptide according
- binds
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202263338629P | 2022-05-05 | 2022-05-05 | |
| US63/338,629 | 2022-05-05 | ||
| US202263351362P | 2022-06-11 | 2022-06-11 | |
| US63/351,362 | 2022-06-11 | ||
| PCT/US2023/066580 WO2023215810A1 (en) | 2022-05-05 | 2023-05-04 | Albumin-binding polypeptides and uses thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025517120A JP2025517120A (ja) | 2025-06-03 |
| JP2025517120A5 true JP2025517120A5 (enExample) | 2026-05-13 |
Family
ID=86688662
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024564796A Pending JP2025517120A (ja) | 2022-05-05 | 2023-05-04 | アルブミン結合ポリペプチド及びその使用 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20250277018A1 (enExample) |
| EP (1) | EP4519311A1 (enExample) |
| JP (1) | JP2025517120A (enExample) |
| CN (1) | CN119137148A (enExample) |
| CA (1) | CA3251817A1 (enExample) |
| TW (1) | TW202406933A (enExample) |
| WO (1) | WO2023215810A1 (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2025144974A1 (en) * | 2023-12-29 | 2025-07-03 | Absci Corporation | Half-life extending fc domain variants and uses thereof |
| WO2025255435A2 (en) * | 2024-06-07 | 2025-12-11 | Odyssey Therapeutics, Inc. | Antigen-binding proteins against serum albumin and uses thereof |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4816567A (en) | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
| US6548640B1 (en) | 1986-03-27 | 2003-04-15 | Btg International Limited | Altered antibodies |
| ATE255131T1 (de) | 1991-06-14 | 2003-12-15 | Genentech Inc | Humanisierter heregulin antikörper |
| ES2375931T3 (es) | 1997-12-05 | 2012-03-07 | The Scripps Research Institute | Humanización de anticuerpo murino. |
| US7217797B2 (en) | 2002-10-15 | 2007-05-15 | Pdl Biopharma, Inc. | Alteration of FcRn binding affinities or serum half-lives of antibodies by mutagenesis |
| EP2284192A3 (en) * | 2002-11-08 | 2011-07-20 | Ablynx N.V. | Camelidae antibodies for sublingual administration |
| ES2393555T3 (es) | 2003-10-22 | 2012-12-26 | Keck Graduate Institute | Métodos para la síntesis de polipéptidos hetero-multiméricos en levaduras usando una estrategia de apareamiento haploide. |
| CA2561686C (en) | 2004-03-31 | 2014-12-02 | Genentech, Inc. | Humanized anti-tgf-beta antibodies |
| US12479909B2 (en) * | 2019-02-22 | 2025-11-25 | Anwita Biosciences, Inc. | Albumin binding antibodies and use thereof |
-
2023
- 2023-05-04 EP EP23728551.5A patent/EP4519311A1/en active Pending
- 2023-05-04 CN CN202380037993.7A patent/CN119137148A/zh active Pending
- 2023-05-04 TW TW112116551A patent/TW202406933A/zh unknown
- 2023-05-04 US US18/861,746 patent/US20250277018A1/en active Pending
- 2023-05-04 JP JP2024564796A patent/JP2025517120A/ja active Pending
- 2023-05-04 CA CA3251817A patent/CA3251817A1/en active Pending
- 2023-05-04 WO PCT/US2023/066580 patent/WO2023215810A1/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7003101B2 (ja) | 交差結合領域の配向性を有する二重可変領域抗体様結合タンパク質 | |
| JP7046804B2 (ja) | 改良された血清アルブミン結合剤 | |
| JP6669722B2 (ja) | Ｃｄ３結合ドメイン | |
| AU2009204501B2 (en) | Method for making antibody Fc-heterodimeric molecules using electrostatic steering effects | |
| JP2009523459A5 (enExample) | ||
| JP2019502656A (ja) | 改善された血清アルブミン結合性免疫グロブリン可変ドメイン | |
| JP2020531438A5 (ja) | Ｎｋｇ２ｄ、ｃｄ１６、およびｈｌａ−ｅに結合するタンパク質 | |
| TW200840821A (en) | Methods of purifying anti A beta antibodies | |
| JP2018510617A5 (enExample) | ||
| RU2015145719A (ru) | Модифицированные асимметричные антитела, связывающие fc-рецептор, и способы их применения | |
| JP6162319B2 (ja) | ヒト化抗ｎ２抗体 | |
| US20240092899A1 (en) | Bispecific antibody | |
| JP7495409B2 (ja) | 改善された抗ｆｌｔ３抗原結合タンパク質 | |
| US20220306760A1 (en) | Igm glycovariants | |
| JP2022542884A (ja) | Ｆｃｒｎアンタゴニストで抗体媒介性障害を処置する方法 | |
| JP2025512865A5 (enExample) | ||
| JP2024537779A5 (enExample) | ||
| JP2024507693A5 (enExample) | ||
| JP2023553694A5 (enExample) | ||
| JP7797203B2 (ja) | 抗ｇａｌ９免疫阻害性結合分子 | |
| JP7657591B2 (ja) | 二重特異性抗原結合コンストラクト | |
| JP2024544936A5 (enExample) | ||
| WO2022125986A1 (en) | Orthogonal mutations for heterodimerization | |
| JP2024523034A5 (enExample) | ||
| EA051713B1 (ru) | Биспецифическое антитело |